5-Fluorouracil-Associated Cardiogenic Shock
- PMID: 31904593
- DOI: 10.1097/MJT.0000000000001129
5-Fluorouracil-Associated Cardiogenic Shock
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Sara JD, Kaur J, Khodadadi R, et al. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol. 2018;10:1758835918780140.
-
- Basselin C, Fontanges T, Descotes J, et al. 5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy. 2011;31:226.
-
- Ozturk MA, Ozveren O, Cinar V, et al. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul Fibrinolysis. 2013;24:90–94.
-
- Akhtar SS, Wani BA, Bano ZA, et al. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report. Tumori. 1996;82:505–507.
-
- David JS, Gueugniaud PY, Hepp A, et al. Severe heart failure secondary to 5-fluorouracil and low-doses of folinic acid: usefulness of an intra-aortic balloon pump. Crit Care Med. 2000;28:3558–3560.
LinkOut - more resources
Full Text Sources